Seattle's Offseason Bet Is a Narrow One — and the Injury List Is Already Testing It
The 2026 Kraken were not a team that ran out of time. They ran out of offense. A 34-48 finish tells one story; the final ten games of the season tell a sharper one. Seattle scored at a 2.0-goals-per-game clip over that stretch, down nearly a full goal from the 2.9 they averaged in the preceding twenty. They closed on a three-game losing streak. The wheels didn't fall off — they dissolved slowly, then all at once, and anyone watching that final month understood that this roster had a structural problem, not a slump.
What makes the offseason moves interesting is that the front office clearly read the same diagnosis. Trading the No. 25 pick to Florida for 23-year-old Mackie Samoskevich on June 21 is not a rebuilding move. It is a "we think we are closer than the record suggests" move — an explicit choice of present-tense talent over future optionality. Locking up Bobby McMann to a six-year extension the same day reinforces the message: this organization believes in its core and is adding around it, not dismantling it. I respect the conviction. The question is whether the core is actually good enough to justify it.
Here is the narrow path to the good outcome. Jordan Eberle produced 17 goals and 33 points in 48 games last season — the team's leading scorer at 18.8 minutes of ice time per night. Matty Beniers ran the second line at nearly 20 minutes a game and put up 32 points in 50 appearances. Vince Dunn drove the power play from the blue line, logging 22-plus minutes per game across 47 contests and finishing with 31 points. Those three are legitimate NHL contributors. Jared McCann, in just 23 games, was scoring at a rate that made him the team's most dangerous offensive weapon per minute of play. If McCann returns healthy and plays a full season, the offensive ceiling of this group rises meaningfully. If Samoskevich — young, Florida-developed, arriving with real pedigree — slots into a top-six role and produces at even a modest rate, Seattle's scoring depth becomes credible rather than fragile. That is the path. It is real.
What breaks that path is not subtle. Joey Daccord has been out since late June and, as of mid-July, has not cleared. Matt Murray remains sidelined as well. A team that finished with a goal differential of -0.45 per game cannot absorb a compromised goaltending situation — that number already reflects a team that was being outscored consistently, and replacing or degrading the starter only accelerates the damage. The Daccord situation is the single most important variable in Seattle's 2026-27 outlook. Not Samoskevich's development curve. Not McMann's deployment. Daccord. A healthy Daccord gives this team a foundation to build on. An extended absence heading into training camp means the Kraken are potentially opening the season with a patchwork solution in net, and this roster does not have the offensive firepower to outscore its problems.
The McCann injury concern compounds this. His 23-game sample last season was both a tantalizing preview and a warning sign — the Kraken got a glimpse of what a healthy McCann looks like and then lost him. He has been out since late June alongside Daccord, and neither has cleared. My read is that the entire offseason calculus — the Samoskevich trade, the McMann extension, the implicit bet on offensive improvement — is contingent on those two returning healthy and early. The front office made the right moves for a team trying to compete. But competing requires the infrastructure to hold. Right now, the two most important variables in Seattle's 2026-27 equation are sitting in the training room, and the schedule is not waiting.
Curtis Douglas signing on adds another piece to the forward depth, and his path to the NHL suggests a player who has earned his roster spot the hard way — that kind of addition has quiet value in a locker room. But no amount of depth-forward signings fixes a broken goaltending situation or replaces a healthy McCann in the lineup. The Kraken's offseason gamble is not reckless — it is reasoned. The problem is that the receipts on that optimism come